Rui Gou

5PUBLICATIONS
3CO-AUTHORS
Molecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Cancer cell biologyPredictive and prognostic markersCancer genetics
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Jun 06, 2026
RAD21 regulation of the enhancer-promoter chromatin loop of RAD51 promotes PARPi resistance in ovarian cancer.

|Sep 22, 2025
Sensitivity of Platinum-Based Chemotherapy and Efficacy of Arsenic Trioxide-Based Non-Platinum Chemotherapy Following the Progression of PARPi Maintenance Therapy: A Real-World Study.

Rui Gou, Qi Xie, Haishan Ren

|Oct 27, 2023
Glycolysis: A fork in the path of normal and pathological pregnancy.

Rui Gou, Xiaohong Zhang

|Nov 02, 2021
Exosomal ANXA2 derived from ovarian cancer cells regulates epithelial-mesenchymal plasticity of human peritoneal mesothelial cells.

Lingling Gao, Xin Nie, Rui Gou

|Jan 30, 2020
Identification of immune-enhanced molecular subtype associated with BRCA1 mutations, immune checkpoints and clinical outcome in ovarian carcinoma.

Mingjun Zheng, Yuexin Hu, Rui Gou

Pageof 1

Frequent Collaborators

3 joint publications

Bei Lin

1 joint publications

Xiaohong Zhang

1 joint publications

Ziyu Li